Showing results (1771-1780 of 2,220) with videos related to
Sort By:
Pageof 222
European Journal of Heart Failure|August 25, 2017
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitorsJaved Butler, Carine E Hamo, Gerasimos Filippatos, et al.Nature Medicine|February 27, 2026
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trialJan-Jaap J Mellema, Chantal F Stockem, Cameron Herberts, et al.Clinical and Translational Medicine|December 27, 2023
The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlasBonan Chen, Wai Nok Chan, Fuda Xie, et al.Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.Journal of Medicinal Chemistry|November 9, 2018
Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)Atwood K Cheung, Brian Hurley, Ryan Kerrigan, et al.Nature Communications|January 20, 2019
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogrammingLei Xiong, Feng Wu, Qiong Wu, et al.Journal of the American Society of Nephrology : JASN|June 24, 2017
Effects of Intensive BP Control in CKDAlfred K Cheung, Mahboob Rahman, David M Reboussin, et al.Journal for Immunotherapy of Cancer|September 13, 2022
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapyLars Guelen, Thierry O Fischmann, Jerelyn Wong, et al.Pharmacological Research|October 24, 2007
Curcumin effects on blood lipid profile in a 6-month human studyLarry Baum, Stanley K K Cheung, Vincent C T Mok, et al.Pageof 222